As of 2025-07-05, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (61.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -280.5%.
The range of the Relative Valuation is (63.08) - (64.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.4x - 28.8x | 27.0x |
| Forward P/E multiples | 14.3x - 21.9x | 14.7x |
| Fair Price | (63.08) - (64.44) | (61.35) |
| Upside | -285.6% - -289.6% | -280.5% |
| Date | P/E |